- Home
- HY vs SYRE Comparison
HY vs SYRE Comparison
Compare HY & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HY
- SYRE
- Stock Information
- Founded
- HY 1991
- SYRE 2013
- Country
- HY United States
- SYRE United States
- Employees
- HY N/A
- SYRE N/A
- Industry
- HY Construction/Ag Equipment/Trucks
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- HY Industrials
- SYRE Health Care
- Exchange
- HY Nasdaq
- SYRE Nasdaq
- Market Cap
- HY 735.1M
- SYRE 841.4M
- IPO Year
- HY N/A
- SYRE 2016
- Fundamental
- Price
- HY $38.43
- SYRE $15.01
- Analyst Decision
- HY Strong Buy
- SYRE Buy
- Analyst Count
- HY 1
- SYRE 6
- Target Price
- HY $70.00
- SYRE $55.00
- AVG Volume (30 Days)
- HY 55.5K
- SYRE 483.8K
- Earning Date
- HY 08-05-2025
- SYRE 08-06-2025
- Dividend Yield
- HY 3.72%
- SYRE N/A
- EPS Growth
- HY N/A
- SYRE N/A
- EPS
- HY 5.60
- SYRE N/A
- Revenue
- HY $4,162,100,000.00
- SYRE N/A
- Revenue This Year
- HY N/A
- SYRE N/A
- Revenue Next Year
- HY $2.55
- SYRE N/A
- P/E Ratio
- HY $6.91
- SYRE N/A
- Revenue Growth
- HY N/A
- SYRE N/A
- 52 Week Low
- HY $34.13
- SYRE $10.91
- 52 Week High
- HY $84.44
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- HY 38.89
- SYRE 42.53
- Support Level
- HY $39.33
- SYRE $13.93
- Resistance Level
- HY $42.89
- SYRE $18.01
- Average True Range (ATR)
- HY 1.16
- SYRE 1.14
- MACD
- HY -0.33
- SYRE -0.26
- Stochastic Oscillator
- HY 8.79
- SYRE 20.49
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.